G. Windbichler

发表

Pooled analysis of prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in 8377 breast cancer patients.

N. Brünner, M. Fernö, J. Foekens, 2002, Journal of the National Cancer Institute.

Erythropoietin treatment under polychemotherapy in patients with gynecologic malignancies: a prospective, randomized, double-blind placebo-controlled multicenter study.

P. Sevelda, C. Marth, G. Windbichler, 1997, Gynecologic oncology.

Pooled analysis of prognostic impact of uPA and PAI-1 in breast cancer patients

N. Brünner, M. Fernö, J. Foekens, 2003, Thrombosis and Haemostasis.

[Ultrasound morphologic evaluation of the postmenopausal endometrium. A prospective study].

C. Marth, E. Müller-Holzner, G. Windbichler, 1996, Gynakologisch-geburtshilfliche Rundschau.

Interferon-gamma in the first-line therapy of ovarian cancer: a randomized phase III trial

H. Hausmaninger, C. Kainz, C. Marth, 2000, British Journal of Cancer.

Long-term significance of urinary neopterin in ovarian cancer: a study by the Austrian Association for Gynecologic Oncology (AGO).

D. Fuchs, G. Sliutz, C. Marth, 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

Perinatal Mortality and Advanced Maternal Age

G. Windbichler, W. Oberaigner, H. Leitner, 2013, Gynecologic and Obstetric Investigation.

Ovarian preservation in the surgical treatment of cervical carcinoma.

O. Dapunt, C. Marth, E. Müller-Holzner, 1999, American journal of obstetrics and gynecology.

Parity as an independent prognostic factor in malignant mixed mesodermal tumors of the endometrium.

O. Dapunt, C. Marth, E. Müller-Holzner, 1997, Gynecologic oncology.

[The evaluation of the second-look operation of patients with ovarian carcinoma and tubal carcinoma by means of a retrospective comparison study].

C. Marth, G. Windbichler, E. Mueller-Holzner, 2002, Gynakologisch-geburtshilfliche Rundschau.

Cisplatin resistance is associated with reduced interferon-gamma-sensitivity and increased HER-2 expression in cultured ovarian carcinoma cells.

M. Widschwendter, C. Marth, G. Daxenbichler, 1997, British Journal of Cancer.

Prognostic significance of TPA versus SCC-Ag, CEA and neopterin in carcinoma of the uterine cervix.

D. Fuchs, C. Marth, G. Daxenbichler, 2008, Cancer letters.

Leiomyosarcoma of the uterus: a clinicopathologic multicenter study of 71 cases.

A. Kaider, L. Hefler, C. Kainz, 1999, Gynecologic oncology.

HOXA11 DNA methylation—A novel prognostic biomarker in ovarian cancer

Martin Widschwendter, Matthias Lechner, Georg Goebel, 2008, International journal of cancer.

Methylated NEUROD1 Promoter is a Marker for Chemosensitivity in Breast Cancer

Robin L. Jones, M. Dowsett, I. Jacobs, 2008, Clinical Cancer Research.

Interferon‐gamma in combination with carboplatin and paclitaxel as a safe and effective first‐line treatment option for advanced ovarian cancer: results of a phase I/II study

A. Pelzer, H. Hausmaninger, C. Marth, 2006, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.

Mineral oil paraffins in human body fat and milk.

Koni Grob, H. Concin, H. Ulmer, 2008, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

Circulating immunostimulatory protein 90K and soluble interleukin‐2‐receptor in human ovarian cancer

O. Dapunt, S. Iacobelli, D. Fuchs, 1996, International journal of cancer.

Predictive value of uPA, PAI-1, HER-2 and VEGF in the serum of ovarian cancer patients.

C. Marth, G. Daxenbichler, G. Windbichler, 2000, Anticancer research.

Prognostic parameters in endometrial stromal sarcoma: a clinicopathologic study in 31 patients.

C. Kainz, S. Leodolter, G. Windbichler, 2001, Gynecologic oncology.

Left ventricular function many years after recovery from pre‐eclampsia

G. Windbichler, A. Strasak, A. Ramoni, 2011, BJOG : an international journal of obstetrics and gynaecology.

Interaction of retinoic acid and interferon-alpha in breast cancer cell lines.

M. Widschwendter, C. Marth, G. Daxenbichler, 1996, Anticancer research.

Different effects of interferons, interleukin‐1β and tumor necrosis factor‐α in normal (OSE) and malignant human ovarian epithelial cells

H. Zwierzina, C. Marth, E. Müller-Holzner, 1996 .